In a filing, Cara Therapeutics Inc revealed its SEC’Y; CHIEF COMPLIANCE & G.C. Terrillion Scott unloaded Company’s shares for reported $2285.0 on Apr 05 ’24. In the deal valued at $0.83 per share,2,753 shares were sold. As a result of this transaction, Terrillion Scott now holds 88,247 shares worth roughly $62655.369999999995.
Then, Goncalves Joana sold 2,753 shares, generating $2,285 in total proceeds. Upon selling the shares at $0.83, the CHIEF MEDICAL OFFICER now owns 53,365 shares.
Before that, Posner Christopher sold 5,834 shares. Cara Therapeutics Inc shares valued at $5,192 were divested by the PRESIDENT AND CEO at a price of $0.89 per share. As a result of the transaction, Posner Christopher now holds 180,521 shares, worth roughly $0.13 million.
BofA Securities downgraded its Cara Therapeutics Inc [CARA] rating to an Underperform from a a Neutral in a research note published on March 08, 2023; the price target was decreased to $6 from $13. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “an Overweight”. JP Morgan started covering the stock on August 03, 2021. It rated CARA as “a Neutral”.
Price Performance Review of CARA
On Tuesday, Cara Therapeutics Inc [NASDAQ:CARA] saw its stock fall -0.14% to $0.71. Over the last five days, the stock has lost -14.78%. Cara Therapeutics Inc shares have fallen nearly -4.58% since the year began. Nevertheless, the stocks have fallen -83.24% over the past one year. While a 52-week high of $4.67 was reached on 03/04/24, a 52-week low of $0.50 was recorded on 01/25/24. SMA at 50 days reached $0.8028, while 200 days put it at $1.4663. A total of 0.6 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For CARA Stock
The 24-hour chart illustrates a support level at 0.6542, which if violated will result in even more drops to 0.5995. On the upside, there is a resistance level at 0.7406. A further resistance level may holdings at 0.7723. The Relative Strength Index (RSI) on the 14-day chart is 38.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1065, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.31%. Stochastics %K at 14.96% indicates the stock is a buying.
The most recent change occurred on April 21, 2020 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $33.
